Epclusa for Hepatitis C
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will evaluate a single-visit approach to hepatitis C treatment in patients seen in the emergency department. Participants with hepatitis C will receive rapid testing and, if eligible, hepatitis C medication before leaving the emergency department. The study will also use a smart pillbox, an AI-powered virtual agent, and community health worker support to help participants take their medication as prescribed. Participants will have follow-up visits and testing to assess medication adherence and whether the hepatitis C infection is cured.
Are You a Good Fit for This Trial?
This trial is for people diagnosed with hepatitis C who visit the emergency department. Participants must be eligible to start treatment right away and able to use support tools like a smart pillbox and virtual assistant.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Epclusa (sofosbuvir and velpatasvir)
Trial Overview
The study tests giving hepatitis C medication (Epclusa) during a single emergency room visit, supported by an AI-powered pillbox, virtual agent, and community health worker follow-up to help patients take their medicine correctly.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will receive hepatitis C treatment during the emergency department visit, along with medication adherence support using a cellular-connected smart pillbox, an artificial intelligence-powered virtual agent, and community health worker support. Participants will be followed through treatment completion and follow-up testing.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Patrick Grace
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.